31 related articles for article (PubMed ID: 16603672)
1. Extracellular metallothionein as a therapeutic target in the early progression of type 1 diabetes.
Melchiorre CK; Lynes MD; Bhandari S; Su SC; Potts CM; Thees AV; Norris CE; Liaw L; Tseng YH; Lynes MA
Cell Stress Chaperones; 2024 Apr; 29(2):312-325. PubMed ID: 38490439
[TBL] [Abstract][Full Text] [Related]
2. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies.
Wu X; Xu M; Geng M; Chen S; Little PJ; Xu S; Weng J
Signal Transduct Target Ther; 2023 May; 8(1):220. PubMed ID: 37244925
[TBL] [Abstract][Full Text] [Related]
3.
Smoak P; Burke SJ; Martin TM; Batdorf HM; Floyd ZE; Collier JJ
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625635
[TBL] [Abstract][Full Text] [Related]
4. Key regulatory genes and signaling pathways involved in islet culture: a bioinformatic analysis.
Shi J; Zhang YQ; Hao DD; Fu SH; Meng JL
Int J Clin Exp Pathol; 2021; 14(2):292-303. PubMed ID: 33564361
[TBL] [Abstract][Full Text] [Related]
5. Oral Corticosterone Administration Reduces Insulitis but Promotes Insulin Resistance and Hyperglycemia in Male Nonobese Diabetic Mice.
Burke SJ; Batdorf HM; Eder AE; Karlstad MD; Burk DH; Noland RC; Floyd ZE; Collier JJ
Am J Pathol; 2017 Mar; 187(3):614-626. PubMed ID: 28061324
[TBL] [Abstract][Full Text] [Related]
6. Kinase inhibitors as potential agents in the treatment of multiple myeloma.
Abramson HN
Oncotarget; 2016 Dec; 7(49):81926-81968. PubMed ID: 27655636
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the CCL2 gene in pancreatic β-cells by IL-1β and glucocorticoids: role of MKP-1.
Burke SJ; Goff MR; Updegraff BL; Lu D; Brown PL; Minkin SC; Biggerstaff JP; Zhao L; Karlstad MD; Collier JJ
PLoS One; 2012; 7(10):e46986. PubMed ID: 23056550
[TBL] [Abstract][Full Text] [Related]
8. Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig.
Medicherla S; Ma JY; Reddy M; Esikova I; Kerr I; Movius F; Higgins LS; Protter AA
J Inflamm Res; 2010; 3():9-16. PubMed ID: 22096353
[TBL] [Abstract][Full Text] [Related]
9. Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis.
Noubade R; Krementsov DN; Del Rio R; Thornton T; Nagaleekar V; Saligrama N; Spitzack A; Spach K; Sabio G; Davis RJ; Rincon M; Teuscher C
Blood; 2011 Sep; 118(12):3290-300. PubMed ID: 21791428
[TBL] [Abstract][Full Text] [Related]
10. p38 MAPK inhibition reduces diabetes-induced impairment of wound healing.
Medicherla S; Wadsworth S; Cullen B; Silcock D; Ma JY; Mangadu R; Kerr I; Chakravarty S; Luedtke GL; Dugar S; Protter AA; Higgins LS
Diabetes Metab Syndr Obes; 2009 Jun; 2():91-100. PubMed ID: 21437122
[TBL] [Abstract][Full Text] [Related]
11. An update on the use of NOD mice to study autoimmune (Type 1) diabetes.
Chaparro RJ; Dilorenzo TP
Expert Rev Clin Immunol; 2010 Nov; 6(6):939-55. PubMed ID: 20979558
[TBL] [Abstract][Full Text] [Related]
12. p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse xenograft models of multiple myeloma.
Medicherla S; Reddy M; Ying J; Navas TA; Li L; Nguyen AN; Kerr I; Hanjarappa N; Protter AA; Higgins LS
Anticancer Res; 2008; 28(6A):3827-33. PubMed ID: 19189670
[TBL] [Abstract][Full Text] [Related]
13. AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice.
Merani S; Edgar RL; Toso C; Emamaullee J; Thiesen A; Shapiro AM
Autoimmunity; 2009 Mar; 42(3):242-8. PubMed ID: 19301207
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive review of interventions in the NOD mouse and implications for translation.
Shoda LK; Young DL; Ramanujan S; Whiting CC; Atkinson MA; Bluestone JA; Eisenbarth GS; Mathis D; Rossini AA; Campbell SE; Kahn R; Kreuwel HT
Immunity; 2005 Aug; 23(2):115-26. PubMed ID: 16111631
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors.
Astolfi A; Iraci N; Manfroni G; Barreca ML; Cecchetti V
ChemMedChem; 2015 Jun; 10(6):957-69. PubMed ID: 26012502
[TBL] [Abstract][Full Text] [Related]
16. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
Medicherla S; Protter AA; Ma JY; Mangadu R; Almirez R; Koppelman B; Kerr I; Navas TA; Movius F; Reddy M; Liu YW; Luedtke G; Perumattam J; Mavunkel B; Dugar S; Schreiner GF
J Pharmacol Exp Ther; 2006 Jul; 318(1):99-107. PubMed ID: 16603672
[TBL] [Abstract][Full Text] [Related]
17. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
